4/9
06:02 am
avte
Aerovate Therapeutics, Inc. (NASDAQ: AVTE) had its "outperform" rating re-affirmed by analysts at Wedbush.
Medium
Report
Aerovate Therapeutics, Inc. (NASDAQ: AVTE) had its "outperform" rating re-affirmed by analysts at Wedbush.
4/9
06:02 am
avte
Aerovate Therapeutics, Inc. (NASDAQ: AVTE) had its "outperform" rating re-affirmed by analysts at Wedbush.
Medium
Report
Aerovate Therapeutics, Inc. (NASDAQ: AVTE) had its "outperform" rating re-affirmed by analysts at Wedbush.
4/1
12:17 pm
avte
Aerovate Therapeutics, Inc. (NASDAQ: AVTE) had its "overweight" rating re-affirmed by analysts at Wells Fargo & Company. They now have a $35.00 price target on the stock.
Medium
Report
Aerovate Therapeutics, Inc. (NASDAQ: AVTE) had its "overweight" rating re-affirmed by analysts at Wells Fargo & Company. They now have a $35.00 price target on the stock.
4/1
12:05 pm
avte
Rating for AVTE
Medium
Report
Rating for AVTE
4/1
12:05 pm
avte
Rating for AVTE
Medium
Report
Rating for AVTE
3/25
08:37 am
avte
Rating for AVTE
Low
Report
Rating for AVTE
3/25
08:37 am
avte
Rating for AVTE
Low
Report
Rating for AVTE